Clinical Significance of Tumor Location for Ureteroscopic Tumor Grading in Upper Tract Urothelial Carcinoma
Authors:
- Satoshi KatayamaSKSatoshi Katayama
- Benjamin PradereBenjamin Pradere
- Nico C. GrossmanNGNico C. Grossman
- Aaron M. PotretzkeAPAaron M. Potretzke
- Stephen A. BoorjianSBStephen A. Boorjian
- Alireza GhoreifiAGAlireza Ghoreifi
- Siamak DaneshmandSDSiamak Daneshmand
- Hooman DjaladatHooman Djaladat
- John P. SfakianosJSJohn P. Sfakianos
- Andrea MariAndrea Mari
- Zine-Eddine KheneZKZine-Eddine Khene
- David D’ANdreaDDDavid D’ANdrea
- 1 November 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 38 (11) , 1156-1163
Abstract
Background: Although previous literature shows tumor location as a prognostic factor in upper tract urothelial carcinoma (UTUC), there remains uninvestigated regarding the impact of tumor location on grade concordance and discrepancies between ureteroscopic (URS) biopsy and final radical nephroureterectomy (RNU) pathology. Methods: In this international study, we retrospectively reviewed the records of 1,498 patients with UTUC who underwent diagnostic URS with concomitant biopsy followed by RNU between 2005 and 2020. Tumor location was divided into four sections: the calyceal-pelvic system, proximal ureter, middle ureter, and distal ureter. Patients with multifocal tumors were excluded from the study. We performed multiple comparison tests and logistic regression analyses. Results: Overall, 1,154 patients were included; 54.4% of those with low-grade URS biopsies were upgraded on RNU. In the multiple comparison tests, middle ureter tumors exhibited the highest probability of upgrading, meanwhile pelvicalyceal tumors exhibited the lowest probability of upgrading (73.7% vs 48.5%, p = 0.007). Downgrading was comparable across all tumor locations. On multivariate analyses, middle ureteral location was significantly associated with a low probability of grade concordance (odds ratio [OR] 0.59; 95% confidence interval [CI], 0.35–1.00; p = 0.049) and an increased risk of upgrading (OR 2.80; 95% CI, 1.20–6.52; p = 0.017). The discordance did not vary regardless of caliceal location, including the lower calyx. Conclusions: Middle ureteral tumors diagnosed to be low grade had a high probability to be undergraded. Our data can inform providers and their patients regarding the likelihood of undergrading according to tumor location, facilitating patient counseling and shared decision making regarding the choice of kidney sparing vs RNU.Keywords
This publication has 24 references indexed in Scilit:
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 UpdateEuropean Urology, 2023
- Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: Systematic review and meta-analysisEuropean Journal of Surgical Oncology, 2020
- Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?Clinical Genitourinary Cancer, 2020
- Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial CarcinomaJournal of Urology, 2018
- Which Patients with Upper Tract Urothelial Carcinoma Can be Safely Treated with Flexible Ureteroscopy with Holmium:YAG Laser Photoablation? Long-Term Results from a High Volume InstitutionJournal of Urology, 2018
- Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experienceWorld Journal of Urology, 2016
- A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial CarcinomaEuropean Urology, 2015
- Mixed High and Low Grade Bladder Tumors—Are They Clinically High or Low Grade?Journal of Urology, 2014
- The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical NephroureterectomyEuropean Urology, 2012
- The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer CenterEuropean Urology, 2010